The U.S. dollar has been on a tear the PAST YEAR and a half, and this has certainly been a factor as U.S. stocks have trounced international stocks during that period. But international funds that ...

Currency hedging is crucial for mitigating risks in global investing by managing foreign exchange fluctuations while preserving equity exposure. Our dynamic currency-hedged ETFs have proven to reduce ...

High-net-worth individuals (HNIs) often have investments spread across different countries in today’s globalised world. While this diversification can yield greater returns, it also exposes investors ...

Investors would not be to blame for detesting the international sleeve of their portfolios over the past decade. Coming out of the global financial crisis in 2009, the U.S. equity market has easily ...

The U.S. dollar has been on a tear the PAST YEAR and a half, and this has certainly been a factor as U.S. stocks have trounced international stocks during that period. But international funds that ...

Hedging production currency is probably one of the toughest decisions a producer has to make. It’s the practice of managing losses, not capturing gains. While putting the finishing touches on a ...

While the US dollar was continually getting stronger and sterling was continually getting weaker, British investors rarely needed to worry too much about currency movements. If you held an ...

Last year was not very profitable for many clients in international stocks, and it wasn’t because the stocks fell. Processing Content “Most of the overseas markets, in local terms, were positive,” ...

Using tools like forwards and options, currency-neutral funds hedge foreign-exchange risks. Investing in currency-neutral funds can protect against losses from unfavorable exchange-rate shifts.

Here at MoneyWeek, we encourage readers to avoid falling prey to "home bias" the tendency to be far more heavily invested in your own country's stockmarket than is justified by its global clout. This ...

Novo Nordisk is hedging and building its way around a global tariff war that may threaten the Wegovy maker’s plans to expand in the U.S. Karsten Munk Knudsen, Novo Nordisk’s chief financial officer, ...